No Data
No Data
Progyny (NASDAQ:PGNY) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Rallies 11% This Past Week
Here's Why Progyny (PGNY) Was Under Pressure in Q3
Health Care Roundup: Market Talk
Progyny Is Maintained at Overweight by Barclays
Progyny, Inc. to Present at Jefferies London Healthcare Conference
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $17 to $22
No Data
No Data